ChemChina assures timeline for Syngenta acquisition

· April 26, 2017

In response to speculation in the market, ChemChina reconfirmed on behalf of the Offeror that all regulatory approvals and conditions required for the closing of the offers have been obtained or satisfied. Subject to at least 67 percent of Syngenta’s issued shares and ADSs being validly tendered into the offers and not withdrawn as of […]

ChemChina turns to U.S. antitrust for Syngenta deal

· January 20, 2017

The ChemChina-Syngenta acquisition is making some noise again in mainstream media. The Chinese state-owned chemical company is seeking approval from the U.S. anti-trust regulator’s approval for the proposed $43 billion acquisition  of Syngenta. ChemChina filed documentation required by the Hart-Scott-Rodino Act under the Federal Trade Commission (FTC). The FTC, along with the Justice Department, has […]

Load more